News und Analysen

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass mittlerweile über drei Milliarden biologische Proben mit seinen Verbrauchsmaterialien verarbeitet wurden. Dieser

The United States Court of Appeals for the Ninth Circuit has ruled in favor of AMN Healthcare (NYSE: AMN) against Aya Healthcare’s protracted legal case, stating categorically that Aya failed to

Kelly Rakowski, Group President and Chief Operating Officer, Strategic Talent Solutions, at AMN Healthcare (NYSE: AMN), has received the 2021 Inclusive Leadership Award from the National Diversity

Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year 2021 fourth quarter and full year ended June 30, 2021 and issued its fiscal-year 2022 financial guidance.

"We are

ChristianaCare, one of the nation’s most dynamic healthcare providers headquartered in Wilmington, Delaware, has selected Premier Inc.’s (NASDAQ: PINC) industry-leading supply chain solutions, to

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced the early retirement of its $450 million five-year senior secured term loan (the Term Loan)

UnityPoint Health, a leading network of hospitals, clinics and home care services across the Midwest, has partnered with Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare

QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) and GT Molecular, a leader in providing customizable, highly sensitive digital PCR and qPCR tests based in the U.S., have started to offer a

QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) und GT Molecular, ein führender Anbieter anpassbarer, hochsensitiver digitaler PCR- und qPCR-Tests mit Sitz in den USA, bieten seit Kurzem eine

QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) and OncXerna Therapeutics, Inc. (“OncXerna”), a precision medicine company using an innovative RNA-expression based biomarker platform to predict

QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) und OncXerna Therapeutics, Inc. („OncXerna“) haben heute den Abschluss eines Rahmenvertrags über die Entwicklung eines NGS-Begleitdiagnostikums für

Nurse practitioners topped the list of most recruited providers in the annual report on physician and advanced practitioner recruiting trends produced by Merritt Hawkins, a leading medical search

Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced that it is branding its comprehensive technology and services platform “PINC AI,” effective immediately.

The

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute bekannt, dass das Unternehmen von der U.S. Food and Drug Administration (FDA) die Notfallzulassung (EUA) für seinen QIAreach® SARS

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its QIAreach^® SARS CoV-2

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 36-cents per share on the Company’s capital stock, payable on September 2, 2021

Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced that its Board of Directors approved a share repurchase program under which the company may repurchase up to $250

AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2021

Lutheran Health Network of Indiana, LLC and Acadia Healthcare Company today held a groundbreaking ceremony for Maple Heights Behavioral Health, a new 120-bed inpatient behavioral health facility in

Regulatory News:

Vifor Pharma Group reported profitable revenue growth in H1 supported by a strong recovery in Ferinject^® / Injectafer^® with sales up 22.8% at CER as a result of improved patient

Regulatory News:

Die Vifor Pharma Gruppe erzielte im 1. Halbjahr 2021 ein profitables Umsatzwachstum dank einer starken Erholung von Ferinject^®/Injectafer^® mit einem Umsatzplus von 22.8% zu kWk

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2021. For the quarter, revenue was $914.6 million, an increase of 34.0% from $682.6

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that it has priced an underwritten offering of 3,636,364 ordinary shares at a price to the

Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to participate in a fireside chat at the KeyBanc Capital